Leads strategic and tactical Quality Planning activities with cross-functional stakeholders across Verily’s medical device, research, and commercial programs, including Software as a Medical Device (SaMD), AI/ML and generative AI applications, consumer health, and medical research contexts, ensuring quality frameworks are fit-for-purpose across each domain. Develops and advances quality oversight frameworks for AI/ML and generative AI products, including considerations for model validation, monitoring, algorithmic change protocols, and alignment with emerging regulatory guidance (e.g., FDA’s AI/ML-based SaMD action plan, predetermined change control plans).